Contents:

1. INTRODUCTION 1.1 Project Objectives 7 1.2 Geographic Scope 7 1.3 Methodology 8 1.4 Respondent Population 8 1.5 Definitions 10 Point of Care Tests 10 Glucose 10 Haemoglobin 11 Arterial blood gas & Electrolytes 11 Acid Base 12 Haemostasis 13 Homeostasis 13 Rapid Cardiac Tests 14 Drugs of Abuse 14 2. PROVISION OF HEALTH CARE 15 2.1 Switzerland 15 Primary Health Care 15 Secondary Health Care 15 2.2 Austria 16 Primary Health Care 16 Secondary Health Care 17 2.3 Italy 17 Primary Health Care 17 Secondary Health Care 17 2.4 Germany 19 Primary Health Care 19 Secondary Health Care 20 2.5 Benelux 20 Primary Health Care 20 Secondary Health Care 21 SECTION 1: POINT OF CARE TESTING AMONGST END USERS 22 3 THE USE OF POINT OF CARE TESTS 23 3.1 Use of POC tests amongst GPs 23 Switzerland 24 Italy 25 Austria 26 Germany 27 Benelux 28 3.2 Use of POC tests in Hospitals 29 Switzerland 32 Italy 33 Austria 34 Germany 35 Benelux 35 Summary 37 3.3 Reasons to run Point of Care Tests 37 Switzerland 39 Italy 39 Austria 40 Germany 41 Benelux 41 Conclusion 42 3.4 Future Change in Point of Care Test Usage by End User Prediction 43 Switzerland 43 Italy 44 Austria 46 Germany 47 Benelux 48 Conclusion 48 4. CENTRALIZATION OF HEALTH CARE SERVICES 50 Switzerland 50 Italy 50 Austria 50 Germany 50 Benelux 51 Conclusion 52 5. STORAGE OF POINT OF CARE TEST RESULTS & NEED FOR HOSPITAL SOFTWARE Switzerland 54 Italy 55 Austria 55 Germany 56 Benelux 57 Conclusions: Healthcare IT 58 6. END USER PERCEPTION OF POC TESTS 59 6.1 Glucose 59 6.2 Haemoglobin 62 6.3 Arterial blood gas 62 6.4 Electrolytes 63 6.5 Haemostasis 63 6.6 Homeostasis 63 6.7 Rapid Cardiac Tests 63 6.8 Other Tests Used 64 6.9 Products in Development 65 6.10 Desired Products 66 Switzerland 66 Austria 66 Italy 66 Germany 67 Benelux 67 7. KEY FINDINGS AND CONCLUSIONS 68 SECTION II: MANUFACTURERS 69 8. MARKET PARTICIPANTS 70 8.1 Company Market Shares—by Product Type72 Glucose POCT 72 ABG/Electrolytes 73 Haemostasis POCT 74 Homeostasis POCT 75 Rapid Cardiac POCT 75 POCT IT Connectivity 76 8.2 Company Profiles 77 Abbott Laboratories 77 Bayer 77 Axis-Shield plc 78 Beckman Coulter 78 Dade Behring 79 Instrumentation Laboratory 79 A. Menarini Diagnostics 79 Radiometer 80 Roche 80 Others 80 9. MARKET SIZES FOR THE POINT OF CARE TEST MARKET 82 9.1 The Market Size by Country 83 Country totals in € 83 Switzerland 86 Italy 87 Austria 89 Germany 91 Benelux 93 9.2 Market Size by POC Test 95 Glucose 95 Glucose Patient Self Tests 96 Urine test strips 97 Haemoglobin 97 Arterial blood gas (ABG) 98 Electrolytes 99 Acid-base 100 Haemostasis 102 Homeostasis 103 Rapid Cardiac Tests 103 Drugs of Abuse Testing 104 Infectious Diseases 105 Multiple, or Panel, Tests 106 Sample of New Products & Technologies 107 Connectivity Products 107 The E-Health Trend & Its Impact on IVD 108 IT Connectivity in the US 108 9.3 The European Union’s IVD Directive 110 9.4 Will POC testing overcome laboratory testing 111 10. KEY MARKET PREDICTIONS EUROPE 112 11. RECOMMENDATIONS 113 11.1 Country Specific Business Recommendations113 Switzerland 113 Austria 114 Italy 114 Germany 115 Benelux 115 12. RECOMMENDATIONS FOR NEXT STEPS116 13. APPENDICES 118 13.1 Industry questionnaire 118 13.2 End User Questionnaire 122 13.3 Abbreviations 125 13.4 Selected contact numbers 126 13.5 Secondary sources of information 128